Brief: Reneo Pharmaceuticals Appoints Michael Cruse Chief Operating Officer
07/03/2022 14:17
March 7 (Reuters) - Reneo Pharmaceuticals Inc RPHM.O :
* RENEO PHARMACEUTICALS INC - MICHAEL P. CRUSE APPOINTED
CHIEF
OPERATING OFFICER
Source text for Eikon: ID:nGNX8k2ByV
Further company coverage: RPHM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Onkure Therapeutics
See all newsBrief: Onkure Therapeutics Inc Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Onkure Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Onkure Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary
Onkure Therapeutics Inc expected to post a loss of $1.46 a share - Earnings Preview
U.S. RESEARCH ROUNDUP-F5, Nextracker, Stryker